Stockscreener 앱 받기
0.271
3.21%
-0.009
시장 영업 전:
.28
0.009
+3.32%
전일 마감가:
$0.28
열려 있는:
$0.2725
하루 거래량:
441.34K
Relative Volume:
0.34
시가총액:
$4.47M
수익:
$1.27M
순이익/손실:
$-11.28M
주가수익비율:
-0.0121
EPS:
-22.4496
순현금흐름:
$-10.46M
1주 성능:
-4.98%
1개월 성능:
-11.73%
6개월 성능:
-48.38%
1년 성능:
+32.20%
1일 변동 폭
$0.2613
$0.2755
1주일 범위
$0.2613
$0.299
52주 변동 폭
$0.0922
$12.00
Azitra Inc Stock (AZTR) Company Profile
명칭
Azitra Inc
전화
203 646 6446
주소
21 Business Park Drive, Branford
AZTR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AZTR
Azitra Inc
|
0.271 | 4.70M | 1.27M | -11.28M | -10.46M | -22.45 |
|
ONC
Beone Medicines Ltd Adr
|
246.68 | 25.81B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.09 | 111.46B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.30 | 40.37M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.39 | 64.44B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
77.49 | 6.19B | 0 | -153.72M | -103.81M | -2.00 |
Azitra Inc 주식(AZTR)의 최신 뉴스
Revolutionary Skin Microbiome Treatment Could Help Cancer Patients Stay on Life-Saving Therapy - Stock Titan
FY2025 EPS Estimates for Azitra Lifted by Zacks Small Cap - Defense World
What is Zacks Small Cap’s Forecast for Azitra Q2 Earnings? - Defense World
AZTR: ATR-04 Trial to Dose 1st Patient Mid-2025 - MSN
Azitra (NYSEAMERICAN:AZTR) Trading Up 0.9% – Time to Buy? - Defense World
Azitra, Inc. to Present Abstract at American Society of Gene and Cell Therapy Highlighting Phase 1/2 Study Targeting Cancer Therapy-Associated Rash - Seeking Alpha
Azitra, Inc. Announces Q1 2025 Results and Provides Business Updates - Nasdaq
Azitra Advances Novel Skin Disease Treatments: Key Trial Results Expected in 2025 - Stock Titan
Stock Of Azitra Inc (AMEX: AZTR) Jumped By 6.67 Percent Over The Past Month, Is There Room For Upside? - Marketing Sentinel
Azitra Inc (AZTR)’s Day in Review: Closing at 0.30, Down by -6.51 - DWinneX
Azitra Inc (AZTR) Stock: Navigating Drops and Gains - investchronicle.com
Azitra Inc [AZTR] Investment Appeal on the Rise - knoxdaily.com
Azitra Inc (AMEX:AZTR) stock: You might be surprised - uspostnews.com
Stocks of Azitra Inc (AZTR) are poised to climb above their peers - Sete News
Azitra (AZTR) Secures Funding Through $20 Million Share Purchase Agreement - GuruFocus
What to expect from Azitra Inc’s (AZTR) current quarter earnings? - uspostnews.com
AZTR’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com
Branford-based biopharma Azitra Inc. gains $20M in partnership deal with Alumni Capital - Hartford Business Journal
Azitra (AZTR) to Highlight Precision Dermatology Advances at Bru - GuruFocus
Market Momentum: Azitra Inc (AZTR) Registers a 3.73 Increase, Closing at 0.31 - DWinneX
Azitra, Inc. to Present ATR-04 Program Update at ASCO 2025 - The Victoria Advocate
Why Coursera Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket - Benzinga
Azitra enters share purchase agreement with Alumni Capital for up to $20M - MSN
Azitra secures funding deal for dermatology treatments By Investing.com - Investing.com India
Azitra secures funding deal for dermatology treatments - Investing.com
$20M Strategic Investment Accelerates Azitra's Breakthrough Treatments for 150,000 Rare Disease Patients - Stock Titan
Azitra (NYSEAMERICAN:AZTR) Trading Up 3.9% – Here’s Why - Defense World
Azitra Announces Proposed Public Offering of Common Stock (PR Newswire) - Aktiellt
Azitra, Inc. (NYSEAMERICAN:AZTR) Shares Acquired by Virtu Financial LLC - Defense World
Teacher Retirement System of Texas Makes New $236,000 Investment in Grail, Inc. (NASDAQ:GRAL) - Defense World
Azitra (AZTR) Expected to Announce Quarterly Earnings on Friday - Defense World
Azitra to Present at Microbiome Times Partnering Forum – Company Announcement - Financial Times
Azitra to Present at Microbiome Times Partnering Forum - PR Newswire
Microbiome Disease Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 140+ Companies and 180+ Therapies | DelveInsight - GlobeNewswire
AZTR: Netherton Topline Expected by Year-End - MSN
Azitra, Inc. (NYSEAMERICAN:AZTR) Short Interest Up 144.1% in February - Defense World
Azitra, Inc. Announces Full Year 2024 Financial Results and Provides Business Updates - Citizentribune
Azitra, Inc. Announces FY 2024 Financial Results and Business Updates - Defense World
Maxim Group cuts Azitra stock price target to $2 from $3, retains Buy rating - Investing.com
Maxim Group cuts Azitra stock price target to $2 from $3, retains Buy rating By Investing.com - Investing.com South Africa
Volcon, Inc. and GlucoTrack, Inc. See Massive Gains, While Omega Therapeutics and Universe Pharmaceuticals Struggle - HPBL
Azitra Inc (AZTR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.95%
자본화:
|
볼륨(24시간):